AUO [AU OPTRONICS] 6-K: (Original Filing)
[Yes ..... No ..X... Not applicable]
SPU [SkyPeople Fruit Juice] 8-K: Loan Agreement Borrower: SkyPeople Juice Group Co., Ltd.
[Loan Agreement Borrower: SkyPeople Juice Group Co., Ltd. st Address: 16F, China Development Bank Tower, No. 2 Gaoxin 1 Lender: SkyPeople International Holdings Group Limited th Address: Scotia Centre, 4 Whereas, the Borrower is willing to borrow loan (in US dollars) from the Lender; and the Lender is also willing to provide loan (in US dollars) to the Borrower. The] [For more information, please contact: COMPANY INVESTOR RELATIONS Xin Ma, CFO David Rudnick, Account Manager SkyPeople Fruit Juice, Inc. CCG Investor Relations Tel: China + 86 - 29-8837-7161 Tel: US +1- 646-626-4172 oliver.x.ma@skypeoplefruitjuice.com Email: david.rudnick@ccgir.com Email: http://www.skypeoplefruitjuice.com Web: http://www.ccgir.com Web: SkyPeople Fruit Juice Receives Funding from a Related Party SPU News XI'AN , China , February 19, 2013 /PRNewswire-Asia-FirstCall/ --] [For more information, please contact: COMPANY INVESTOR RELATIONS Xin Ma, Chief Financial Officer David Rudnick, Account Manager SkyPeople Fruit Juice, Inc. CCG Investor Relations Tel: China + 86 - 29-8837-7161 Tel: US +1- 646-626-4172 oliver.x.ma@skypeoplefruitjuice.com Email: david.rudnick@ccgir.com Email: http://www.skypeoplefruitjuice.com Web: http://www.ccgir.com Web: SkyPeople Fruit Juice Announces Changes in Management and its Board of Directors SPU News XI'AN , China ,] [FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): February 18, 2013 001-34502 SkyPeople Fruit Juice, Inc. (Exact name of small business issuer as specified in its charter) Florida State or other jurisdiction of incorporation or organization) S 98-0222013 (IRS Employer Identification No.) 16F, China Development Bank Tower, No. 2, Gaoxin 1st Road, Xi'an, China 710075 86-29-88377216]
AUO [AU OPTRONICS] 6-K: Yes ….. No ..X… Not applicable
[Yes ..... No ..X... Not applicable]
HOLI [Hollysys Automation Technologies] 6-K: (Original Filing)
[Hollysys Automation Technologies Reports Unaudited Financial Results for Fiscal Year 2013 Second Quarter Ended December 31, 2012 Q2 Financial Highlights • Quarterly revenues of $87.2 million, representing an increase of 8.6% compared to $80.3 million year over year, and a decrease of 1.0% compared to $88.1 million quarter over quarter. • Gross margin at 32.1%, as compared to 38.5% year]
MCOX [Mecox Lane] CORRESP: (Original Filing)
[MECOX LANE LIMITED 22nd Floor, Gems Tower, Building 20 No. 487 Tianlin Road, Shanghai 200233 Peoples Republic of China February 19, 2013 VIA EDGAR AND HAND DELIVERY Tia L. Jenkins , Senior Assistant Chief Accountant Office of Beverages, Apparel and Mining Steve Lo John Archfield Erin Wilson James Lopez , Legal Branch Chief Division of Corporation Finance 100 F Street,]
HOLI [Hollysys Automation Technologies] 6-K: Hollysys Automation Technologies Reports Unaudited Financial Results for
[Hollysys Automation Technologies Reports Unaudited Financial Results for Fiscal Year 2013 Second Quarter Ended December 31, 2012 Q2 Financial Highlights • Quarterly revenues of $87.2 million, representing an increase of 8.6% compared to $80.3 million year over year, and a decrease of 1.0% compared to $88.1 million quarter over quarter. • Gross margin at 32.1%, as compared to 38.5% year]
TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)
[TPI Reports Second Quarter Fiscal Year 2013 Financial Results Tianyin Pharmaceutical Inc. CHENGDU, China, February 14, 2013 -- Second Quarter Fiscal Year 2013 Ended December 31, 2012 Financial Highlights: ● Revenue was $17.6 million compared with $18.2 million in 2Q12 a decrease of 3.3% year over year, ● Operating income was $2.6 million, compared with $2.1 million in 2Q12, an] [Tianyin Pharmaceutical Co., Inc. (“TPI”) Second Quarter of Fiscal Year 2013 Earnings Call February 14, 2013 Operator TPI James Tong Second Quarter Fiscal Year 2013 Ended December 31, 2012 Financial Highlights: ● Revenue totaled $17.6 million compared with $18.2 million in 2Q12, a decrease of 3.3% year over year, ● Operating income was $2.6 million, compared with $2.1 million in] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 14, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
CEO [CNOOC] 6-K: (Original Filing)
[CNOOC Limited]
